annual cash & cash equivalents:
$224.08M-$35.16M(-13.56%)Summary
- As of today (September 10, 2025), AMPH annual cash & cash equivalents is $224.08 million, with the most recent change of -$35.16 million (-13.56%) on December 31, 2024.
- During the last 3 years, AMPH annual cash & cash equivalents has risen by +$84.97 million (+61.08%).
- AMPH annual cash & cash equivalents is now -13.56% below its all-time high of $259.24 million, reached on December 31, 2023.
Performance
AMPH Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$234.19M-$5.13M(-2.14%)Summary
- As of today (September 10, 2025), AMPH quarterly cash & cash equivalents is $234.19 million, with the most recent change of -$5.13 million (-2.14%) on June 30, 2025.
- Over the past year, AMPH quarterly cash & cash equivalents has increased by +$13.98 million (+6.35%).
- AMPH quarterly cash & cash equivalents is now -23.55% below its all-time high of $306.33 million, reached on September 30, 2023.
Performance
AMPH quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AMPH Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.6% | +6.3% |
| 3 y3 years | +61.1% | +26.0% |
| 5 y5 years | +150.3% | +128.3% |
AMPH Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.6% | +61.1% | -23.6% | +39.4% |
| 5 y | 5-year | -13.6% | +150.3% | -23.6% | +128.3% |
| alltime | all time | -13.6% | >+9999.0% | -23.6% | +349.5% |
AMPH Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $234.19M(-2.1%) |
| Mar 2025 | - | $239.32M(+6.8%) |
| Dec 2024 | $224.08M(-13.6%) | $224.08M(-11.4%) |
| Sep 2024 | - | $252.93M(+14.9%) |
| Jun 2024 | - | $220.21M(-24.6%) |
| Mar 2024 | - | $291.99M(+12.6%) |
| Dec 2023 | $259.24M(+45.5%) | $259.24M(-15.4%) |
| Sep 2023 | - | $306.33M(+82.3%) |
| Jun 2023 | - | $168.02M(-14.0%) |
| Mar 2023 | - | $195.33M(+9.6%) |
| Dec 2022 | $178.20M(+28.1%) | $178.20M(-4.5%) |
| Sep 2022 | - | $186.52M(+0.4%) |
| Jun 2022 | - | $185.83M(-1.9%) |
| Mar 2022 | - | $189.44M(+36.2%) |
| Dec 2021 | $139.11M(+26.8%) | $139.11M(+18.8%) |
| Sep 2021 | - | $117.07M(-15.5%) |
| Jun 2021 | - | $138.54M(+17.8%) |
| Mar 2021 | - | $117.57M(+7.2%) |
| Dec 2020 | $109.68M(+22.5%) | $109.68M(+6.6%) |
| Sep 2020 | - | $102.85M(+0.3%) |
| Jun 2020 | - | $102.55M(+44.0%) |
| Mar 2020 | - | $71.20M(-20.5%) |
| Dec 2019 | $89.52M | $89.52M(-12.6%) |
| Sep 2019 | - | $102.43M(-19.6%) |
| Jun 2019 | - | $127.36M(+48.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $86.08M(-7.8%) |
| Dec 2018 | $93.32M(+28.9%) | $93.32M(+23.3%) |
| Sep 2018 | - | $75.72M(+37.6%) |
| Jun 2018 | - | $55.04M(-10.5%) |
| Mar 2018 | - | $61.53M(-15.0%) |
| Dec 2017 | $72.38M(-2.5%) | $72.38M(-1.6%) |
| Sep 2017 | - | $73.60M(-15.8%) |
| Jun 2017 | - | $87.43M(+10.6%) |
| Mar 2017 | - | $79.03M(+6.4%) |
| Dec 2016 | $74.27M(+10.3%) | $74.27M(+7.9%) |
| Sep 2016 | - | $68.84M(+1.2%) |
| Jun 2016 | - | $68.05M(+5.3%) |
| Mar 2016 | - | $64.62M(-4.1%) |
| Dec 2015 | $67.36M(-2.8%) | $67.36M(-6.4%) |
| Sep 2015 | - | $71.97M(-5.0%) |
| Jun 2015 | - | $75.75M(+8.1%) |
| Mar 2015 | - | $70.08M(+1.1%) |
| Dec 2014 | $69.32M(+26.2%) | $69.32M(-6.8%) |
| Sep 2014 | - | $74.38M(+13.4%) |
| Jun 2014 | - | $65.58M(+22.7%) |
| Mar 2014 | - | $53.46M(-2.6%) |
| Dec 2013 | $54.91M(+5.4%) | $54.91M(+3.1%) |
| Sep 2013 | - | $53.27M(+2.2%) |
| Dec 2012 | $52.10M(>+9900.0%) | - |
| Dec 2012 | - | $52.10M |
| Dec 2011 | $0.00 | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of AMPH is $224.08M
What is the all time high annual cash & cash equivalents for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $259.24M
What is Amphastar Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, AMPH annual cash & cash equivalents has changed by -$35.16M (-13.56%)
What is Amphastar Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AMPH is $234.19M
What is the all time high quarterly cash & cash equivalents for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $306.33M
What is Amphastar Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, AMPH quarterly cash & cash equivalents has changed by +$13.98M (+6.35%)